AGP Picks
View all

Applied Technology News: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Applied Technology News.

Press releases published on May 22, 2026

AVer HUB Series Now Includes 5-Year Warranty, Offering Lasting Support for Hybrid Workspaces
Squirrel Ai Learning’s Derek Li Unveils New IEEE AI Education Standards Working Group at ASU+GSV Summit
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Immix Biopharma Announces Closing of $150 Million Underwritten Offering of Common Stock
EpiCooler AC Claims Evaluated: The EpiCooler Portable AC with Smart Air Cooler Climate Control for Comfortable Room Temperature Support
Multilogin lança preços em dólar em 21 de maio: fluxos de trabalho mais rápidos a partir de US$ 7,08/mês
XRSPACE and Riversoft Debut AI Avatars That Drive Travel Bookings — Live at TTE 2026
Attensi Named in The Sunday Times Best Places to Work 2026 List as One of the Best Places to Work in the UK
Sigma Capital launches healthcare AI investment platform backing surgical data and clinical infrastructure
Greenwich LifeSciences Announces Receipt of Nasdaq Notice Regarding Late Form 10-Q Filing
SHARC Energy Oversubscribes Closing of Third Tranche of Debenture Exercising 25% Overallotment
SCYNEXIS Announces One-for-Eight Reverse Stock Split
NANOBIOTIX Announces Full Exercise of Underwriters’ Over-Allotment Option, Bringing Gross Proceeds of Offering to Approximately $100 Million
NANOBIOTIX annonce l’exercice integral de l’option de surallocation, portant le produit de l'offre a 100 millions de dollars
Maris-Tech Announces Receipt of Nasdaq Notification of Minimum Stockholders’ Equity Non-Compliance
XTL Announces Receipt of Staff Delist Determination from Nasdaq
Abivax Presents First Quarter 2026 Financial Results and Reports Three-Year Interim Data from Study 108, a Phase 2a/2b Open-Label Extension Trial of Obefazimod Following Dose De-Escalation in Patients with Ulcerative Colitis
Abivax présente ses résultats financiers du T1 2026 et les données à trois ans de l’étude 108, un essai d’extension ouvert de phase 2a/2b évaluant l’obéfazimod après réduction de dose dans la RCH
Crinetics Pharmaceuticals to Participate in Jefferies Global Healthcare Conference 2026
Aspire Systems Wins Three Awards at NaviGo Agile & DevOps Awards 2026

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Applied Technology News

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.